Faiza Zafar
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Genetics
- Immunology
- Co-authors
- Roger PearseRubén NiesvizkyMorton ColemanDavid JayabalanTomer M. MarkPaul J. ChristosSelina Chen‐KiangJohn P. Leonard
- Topics
- Multiple Myeloma Research and Treatments (37 papers)Cancer Treatment and Pharmacology (19 papers)Protein Degradation and Inhibitors (16 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Faiza Zafar
36 papers receiving 496 citations
Peers
Comparison fields: 5 of 50
- Hematology 447
- Molecular Biology 370
- Oncology 262
- Genetics 60
- Immunology 27
Countries citing papers authored by Faiza Zafar
This map shows the geographic impact of Faiza Zafar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faiza Zafar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faiza Zafar more than expected).
Fields of papers citing papers by Faiza Zafar
This network shows the impact of papers produced by Faiza Zafar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faiza Zafar. The network helps show where Faiza Zafar may publish in the future.
Co-authorship network of co-authors of Faiza Zafar
This figure shows the co-authorship network connecting the top 25 collaborators of Faiza Zafar. A scholar is included among the top collaborators of Faiza Zafar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faiza Zafar. Faiza Zafar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 13 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 0 | |
| 10 | 0 | |
| 11 | 62 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 9 | |
| 15 | 20 | |
| 16 | 1 | |
| 17 | 79 | |
| 18 | 68 | |
| 19 | 39 | |
| 20 | 13 |
About Faiza Zafar
Faiza Zafar is a scholar working on Hematology, Oncology and Molecular Biology, having authored 40 papers that have together received 507 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), Cancer Treatment and Pharmacology (19 papers) and Protein Degradation and Inhibitors (16 papers). The work is most often cited by research in Hematology (447 citations), Oncology (262 citations) and Genetics (60 citations). Faiza Zafar has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Roger Pearse, Rubén Niesvizky, Morton Coleman, David Jayabalan, Tomer M. Mark, Paul J. Christos, Selina Chen‐Kiang, John P. Leonard, Karen Pekle and Scott Ely. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.